Dong-Ming Yao Selected Research

Dong-Ming Yao Research Topics

17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2010
12	Neoplasms (Cancer) 10/2021 - 02/2009
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 08/2010
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 02/2009
2	Leukemia 01/2019 - 10/2011
1	Pathologic Complete Response 09/2017
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 10/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2011
1	Hematologic Neoplasms (Hematological Malignancy) 07/2011
1	Melanoma (Melanoma, Malignant) 08/2010
1	Carcinoma (Carcinomatosis) 02/2009

6	Biomarkers (Surrogate Marker)IBA 10/2019 - 10/2013
4	Glutathione PeroxidaseIBA 01/2015 - 01/2015
3	Long Noncoding RNAIBA 01/2022 - 01/2018
2	Decitabine FDA Link 01/2019 - 06/2017
2	AntigensIBA 10/2011 - 08/2010
2	Death-Associated Protein KinasesIBA 12/2010 - 02/2009
1	Biological ProductsIBA 01/2019
1	Messenger RNA (mRNA)IBA 04/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	Phosphotransferases (Kinase)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 12/2013
1	Complementary DNA (cDNA)IBA 10/2011
1	CCAAT-Enhancer-Binding ProteinsIBA 07/2011
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2011
1	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2010
1	GTP Phosphohydrolases (GTPases)IBA 08/2010

1	Hematopoietic Stem Cell Transplantation 09/2017
1	Transplantation 09/2017
1	Induction Chemotherapy 04/2017